Last Updated: May 31, 2026

AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride and what is the scope of freedom to operate?

Amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride is the generic ingredient in two branded drugs marketed by Icu Medical Inc and Abbott, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE

US Patents and Regulatory Information for AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott AMINOSYN 3.5% M IN PLASTIC CONTAINER amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride INJECTABLE;INJECTION 018875-002 Aug 8, 1984 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Abbott AMINOSYN 3.5% M IN PLASTIC CONTAINER amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride INJECTABLE;INJECTION 018804-002 May 15, 1984 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Icu Medical Inc AMINOSYN 3.5% M amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride INJECTABLE;INJECTION 017789-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Select Pharmaceutical Ingredients

Last updated: February 20, 2026

This analysis covers amino acids, magnesium acetate, phosphoric acid, potassium acetate, and sodium chloride, focusing on supply chains, market size, growth drivers, regulatory trends, and financial outlooks.

What Are the Market Sizes and Growth Rates?

Ingredient Estimated Global Market Size (2022) Compound Annual Growth Rate (2022–2027)
Amino acids $4.8 billion 8%
Magnesium acetate $150 million 6%
Phosphoric acid $3.2 billion 3%
Potassium acetate $400 million 7%
Sodium chloride $10 billion 2%

Amino acids dominate within the market, driven by expanding applications in nutraceuticals, pharmaceuticals, and injectables. Sodium chloride holds the largest volume share, mainly as a bulk excipient and saline solution. Growth rates vary based on application-specific demand, with amino acids and potassium acetate experiencing higher expansion.

What Are the Key Market Drivers?

Amino Acids

  • Rising demand for nutritional supplements, especially in Asia.
  • Increased use as injectables for chemotherapy and amino acid-based therapies.
  • Expansion in animal feed and aquaculture sectors.

Magnesium Acetate

  • Growing use in food additives and as a magnesium supplement.
  • Use in industrial applications, including de-icing and flame retardants.
  • Rising adoption in pharmaceutical formulations as a magnesium source.

Phosphoric Acid

  • Predominantly used in fertilizer production; downstream pharmaceutical use is limited.
  • Moderate growth tied to fertilizer markets in emerging economies.
  • Demand remains steady in dental and dental care products.

Potassium Acetate

  • Increasing application as a de-icer and airflow agent.
  • Growing use as a pharmaceutical excipient and electrolyte replenisher.

Sodium Chloride

  • Demand driven from saline infusions, dialysis, and manufacturing.
  • Growth constrained by market saturation and substitution by alternative electrolytes.

How Do Supply Chains and Regulatory Factors Affect Market Trajectories?

Supply Chain Considerations

  • Amino acids are primarily produced via microbial fermentation and chemical synthesis; supply is concentrated in China and India, making markets susceptible to geopolitical and trade policies.
  • Magnesium acetate and potassium acetate are produced through chemical reactions involving raw mineral sources; supply is limited by raw material availability.
  • Phosphoric acid largely depends on phosphate rock mining; geopolitical stability affects pricing and supply reliability.
  • Sodium chloride benefits from global salt production but faces environmental scrutiny due to land use and mining practices.

Regulatory Environment

  • Amino acids are subject to stringent quality standards under USP and EP, with recent updates emphasizing purity and safety.
  • Magnesium acetate and potassium acetate are largely under chemical safety regulations; use in pharmaceuticals requires compliance with FDA and EMA guidelines.
  • Phosphoric acid's use in food and medical applications faces regulatory scrutiny on residual impurities.
  • Sodium chloride must meet pharmacopeial standards for injectable and oral uses.
  • Overall, regulatory harmonization efforts aim to streamline manufacturing standards worldwide but introduce compliance costs.

What Is the Financial Outlook for These Ingredients?

Revenue Trends

  • Amino acids maintain consistent double-digit growth, driven by expanding application bases and bulk manufacturing cost reductions.
  • Magnesium acetate’s niche applications foster steady growth but limit market share expansion.
  • Phosphoric acid growth remains modest; price stability is influenced by phosphate rock costs.
  • Potassium acetate experiences rapid growth in niche markets, driven by its multifunctional applications.
  • Sodium chloride’s revenue growth remains stable; volume increases are offset by pricing pressures.

Profitability and Investment Patterns

  • Major players invest in capacity expansion for amino acids, emphasizing fermentation technology efficiencies.
  • Vertical integration is improving margins for chemical intermediates like magnesium and potassium acetates.
  • Regulatory compliance costs increase operational expenses, slightly compressing margins.
  • Private equity and strategic acquisition activity target high-growth segments like amino acids and potassium acetate.

Future Financial Risks

  • Supply chain disruptions due to geopolitics or raw material shortages.
  • Regulatory changes increasing compliance costs.
  • Price volatility in raw materials, especially phosphate ore and mineral salts.
  • Market saturation in sodium chloride sectors could limit revenue growth.

What Are the Strategic Recommendations?

  • Companies should monitor geopolitical shifts impacting raw material supply, especially phosphate rock and mineral sources.
  • Investment in scalable fermentation processes for amino acids can yield cost advantages.
  • Diversification into niche markets like magnesium and potassium acetate may provide growth buffers.
  • Enhance regulatory compliance to minimize operational risks and access premium markets.

Key Takeaways

  • The amino acids market exhibits the highest growth and revenue potential, primarily driven by nutraceutical and pharmaceutical applications.
  • Sodium chloride remains a mature, volume-driven market with stable but slower growth.
  • Supply chain risks and regulatory hurdles are critical factors influencing profitability and expansion.
  • Innovation in fermentation and chemical synthesis processes offers competitive advantages.
  • Market growth is uneven; high growth in amino acids and potassium acetate contrasts with slower trends in phosphoric acid and sodium chloride.

FAQs

  1. Which ingredient offers the highest growth potential?
    Amino acids show the highest CAGR at 8% through 2027, fueled by expanding applications in nutrition and therapeutics.

  2. What are the main supply risks for these ingredients?
    Raw material shortages, geopolitical tensions, and environmental regulations threaten supply stability, especially for phosphate-based products.

  3. How are regulatory changes impacting these markets?
    Regulations focusing on purity, safety, and environmental impact increase costs but create barriers to entry, favoring established manufacturers.

  4. Which segments are driving innovation?
    Nutraceutical and pharmaceutical sectors primarily invest in fermentation and chemical process improvements for amino acids and acetate derivatives.

  5. What are the key financial risks for investors?
    Market saturation, raw material price volatility, and compliance costs pose ongoing risks, particularly for commodity-based ingredients like sodium chloride.


References

[1] MarketsandMarkets. (2022). Amino acids market analysis & forecasts.
[2] Grand View Research. (2023). Specialty chemicals market size and growth.
[3] U.S. Food and Drug Administration. (2022). Regulatory guidelines for pharmaceutical excipients.
[4] International Fertilizer Association. (2022). Phosphoric acid and fertilizer demand trends.
[5] PricewaterhouseCoopers. (2023). Chemical industry financial review.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.